نتایج جستجو برای: ciclopirox olamine

تعداد نتایج: 195  

Journal: :Skin appendage disorders 2015
Aditya K Gupta Deanne Daigle Kelly A Foley

BACKGROUND Many onychomycosis treatments have not been directly compared in head-to-head clinical trials. OBJECTIVE To determine the relative efficacy of onychomycosis treatments using network meta-analysis (NMA). METHODS We conducted a systematic review and NMA of mycological cure rates. RESULTS Nineteen trials were included in the network. Terbinafine 250 mg was significantly superior t...

Journal: :Journal of the American Podiatric Medical Association 2006
Erin M Warshaw

Onychomycosis is a common problem. The desired outcome of treatment for patients and clinicians is complete cure (negative culture and negative potassium hydroxide examination results plus a completely normal nail). This cost analysis sought to determine the cost-effectiveness of treatments for onychomycosis using complete cure as a unit of effectiveness. A simplified cost-effectiveness analysi...

2018
Baisheng Yuan Wei Ji Haipeng Xia Jianmin Li

Ciclopirox (CPX) is a synthetic antifungal drug that is mainly used to treat dermatomycoses. The aim of the present study was to determine whether CPX could influence Ewing sarcoma progression. The present study suggested that CPX treatment may inhibit Ewing sarcoma (ES) progression through Ewing sarcoma breakpoint region 1‑Friend leukemia integration 1 (EWS‑FLI1), a common fusion transcript st...

2013
In-Young Choi Ji-Hyae Lim Chunsook Kim Hwa Young Song Chung Ju Won-Ki Kim

N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity is one of the major causes for neuronal cell death during cerebral ischemic insult. Previously, we reported that the final product of lipid membrane peroxidation 4-hydroxy-2E-nonenal (HNE) synergistically increased NMDA receptor-mediated excitotoxicity (J Neurochem., 2006). In this study, we investigated the mechanism involved in the ...

Journal: :BMJ clinical evidence 2006
Jill Ferrari

INTRODUCTION Fungal infections are reported to cause 23% of foot diseases and 50% of nail conditions in people seen by dermatologists, but are less common in the general population, affecting 3% to 12% of people. METHODS AND OUTCOMES We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of oral treatments for fungal toenail infections in a...

2015
Enembe O Okokon Jos H Verbeek Jani H Ruotsalainen Olumuyiwa A Ojo Victor Nyange Bakhoya

BACKGROUND Seborrhoeic dermatitis is a chronic inflammatory skin condition that is distributed worldwide. It commonly affects the scalp, face and flexures of the body. Treatment options include antifungal drugs, steroids, calcineurin inhibitors, keratolytic agents and phototherapy. OBJECTIVES To assess the effects of antifungal agents for seborrhoeic dermatitis of the face and scalp in adoles...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید